Reply to the Correspondence Regarding: “Short-Course Potent P2Y12 Inhibitor–Based DAPT Versus Clopidogrel-Based DAPT After PCI: A Propensity-Matched Real-World Study”
本文未提供摘要，请点击“查看全文”查看完整内容。